# RQM+

> Evolving MedTech

## Full Content Export
- **URL**: https://www.rqmplus.com/llms-full.txt

### Posts

- [“Toto…We're Not in Brussels Anymore”. Accounting for National Legislation on the Yellow Brick Road to CE marking](https://www.rqmplus.com/blog/totowere-not-in-brussels-anymore-accounting-for-national-legislation-on-the-yellow-brick-road-to-ce-marking/)
- [5 Key Elements of GMP in the Food Industry](https://www.rqmplus.com/blog/key-elements-gmp-food-industry/)
- [5 Tips for IVDR Certification of Companion Diagnostics](https://www.rqmplus.com/blog/5-tips-for-ivdr-certification-of-companion-diagnostics/)
- [510(k)-Exempt Devices](https://www.rqmplus.com/blog/2013-09-510k-exempt-devices/)
- [8 Strategic Advantages of Outsourcing Audits](https://www.rqmplus.com/blog/8-strategic-advantages-outsourcing-audits/)
- [A Beginner’s Guide to Dynamic Mechanical Analysis](https://www.rqmplus.com/blog/guide-dynamic-mechanical-analysis/)
- [A Comparison of IVDR to FDA IVD Regulatory Submission Requirements](https://www.rqmplus.com/blog/a-comparison-of-ivdr-to-fda-ivd-regulatory-submission-requirements/)
- [A Quantitative Approach to Benefit-Risk Determination](https://www.rqmplus.com/blog/a-quantitative-approach-to-benefit-risk-determination-rqm/)
- [Addressing Unmet Needs in Women's Health: Devices for Mental Health Support](https://www.rqmplus.com/blog/addressing-unmet-needs-in-womens-health-devices-for-mental-health-support/)
- [AI/ML-Enabled Medical Devices: Recognition & Reliance in the UK](https://www.rqmplus.com/blog/ai-ml-enabled-medical-devices-recognition-reliance-in-the-uk/)
- [Ambulatory Cardiac Monitoring Devices: Is Your Evidence Compelling or Just Adequate?](https://www.rqmplus.com/blog/ambulatory-cardiac-monitoring-devices-is-your-evidence-compelling-or-just-adequate/)
- [An Overview of Chemical Characterization of Medical Devices](https://www.rqmplus.com/blog/an-overview-of-chemical-characterization-of-medical-devices/)
- [An Overview of Toxicological Risk Assessments](https://www.rqmplus.com/blog/overview-toxicological-risk-assessments/)
- [Approved, Covered, Adopted: Why Reimbursement Strategy Has to Come First ](https://www.rqmplus.com/blog/approved-covered-adopted-why-reimbursement-strategy-has-to-come-first/)
- [Are High-Quality PMCF Surveys Enough for High-Risk Devices?](https://www.rqmplus.com/blog/pmcf-surveys-high-risk-devices/)
- [Artificial Neural Network Supporting Biological Neural Networks](https://www.rqmplus.com/blog/artificial-neural-network-supporting-biological-neural-networks/)
- [Beyond Inclusion: Reimagining Equity and Real-World Impact in Heart Failure Trials](https://www.rqmplus.com/blog/beyond-inclusion-reimagining-equity-and-real-world-impact-in-heart-failure-trials/)
- [Braving the Tariff Storm: Strategies for MedTech Companies](https://www.rqmplus.com/blog/braving-the-tariff-storm-strategies-for-medtech-companies/)
- [Breaking New Ground: Introducing the Transitional Coverage for Emerging Technologies (TCET) Pathway](https://www.rqmplus.com/blog/breaking-new-ground-introducing-the-transitional-coverage-for-emerging-technologies-tcet-pathway/)
- [Bridging CDER, CBER, and CDRH: Surviving the Regulatory Bermuda Triangle of Combination Products](https://www.rqmplus.com/blog/bridging-cder-cber-and-cdrh-surviving-the-regulatory-bermuda-triangle-of-combination-products/)
- [Bridging the Real-World Evidence Gap in MedTech - A practitioner’s guide to applying real-world data in regulatory strategy.](https://www.rqmplus.com/blog/bridging-the-real-world-evidence-gap-in-medtech-a-practitioners-guide-to-applying-real-world-data-in-regulatory-strategy/)
- [Bridging Treatment Gaps in Heart Failure with Reduced Ejection Fraction: Advancing Evidence for Device-Based Therapies](https://www.rqmplus.com/blog/bridging-treatment-gaps-in-heart-failure-with-reduced-ejection-fraction-advancing-evidence-for-device-based-therapies/)
- [Brought to You by the Letter M: Operational Considerations for Transitioning From the QSR to the QMSR](https://www.rqmplus.com/blog/brought-to-you-by-the-letter-m-operational-considerations-for-transitioning-from-the-qsr-to-the-qmsr/)
- [Characterizing Polymers for Novel Sustainability Initiatives](https://www.rqmplus.com/blog/characterizing-polymers-sustainability-initiatives/)
- [Checklist for Navigating PFAS Phase-Out in MedTech](https://www.rqmplus.com/blog/checklist-for-navigating-pfas-phase-out-in-medtech/)
- [Chemical Characterization Testing of Medical Devices](https://www.rqmplus.com/blog/chemical-characterization-testing-medical-devices/)
- [Christmas Tree: Artificial or Real](https://www.rqmplus.com/blog/oh-christmas-tree/)
- [Classification for SARS-CoV-2: Adjusting to a Post-Pandemic Reality Under IVDR](https://www.rqmplus.com/blog/classification-for-sars-cov-2-adjusting-to-a-post-pandemic-reality-under-ivdr/)
- [Code Red: How Reimbursement Fails MedTech’s Best and Brightest](https://www.rqmplus.com/blog/code-red-how-reimbursement-fails-medtechs-best-and-brightest/)
- [Common Causes of Polymer Failure](https://www.rqmplus.com/blog/common-causes-polymer-failure/)
- [Contaminant Analysis: How to Interpret Particulate Matter](https://www.rqmplus.com/blog/contaminant-analysis-particulate-matter/)
- [Contamination Detection: Particulates and Residue Analysis with RQM+ Lab Services](https://www.rqmplus.com/blog/particulates-residue-analysis/)
- [Defining Usability Objectives](https://www.rqmplus.com/blog/2012-08-defining-usability-objectives/)
- [Determining the Primary Endpoint in Clinical Research](https://www.rqmplus.com/blog/determining-the-primary-endpoint-in-clinical-research/)
- [Devices for the Military](https://www.rqmplus.com/blog/2013-12-devices-military/)
- [Don't Get Caught Off Guard: How to Meet the EU's 2024 MDR Deadlines](https://www.rqmplus.com/blog/dont-get-caught-off-guard-how-to-meet-the-eus-2024-mdr-deadlines/)
- [Embracing Recalls](https://www.rqmplus.com/blog/embracing-recalls/)
- [Engineering Plastics via Gel Permeation Chromatography](https://www.rqmplus.com/blog/engineering-plastics-gel-permeation-chromatography/)
- [Enhancing Competitiveness in MedTech: Smart Strategies with Regulatory Intelligence](https://www.rqmplus.com/blog/enhancing-competitiveness-in-medtech-smart-strategies-with-regulatory-intelligence/)
- [Enough Is Enough: Deciding When Your Safety Evaluation Is Complete](https://www.rqmplus.com/blog/enough-is-enough-deciding-when-your-safety-evaluation-is-complete/)
- [Ensuring Compliance with FDA’s Final Rule for Laboratory Developed Tests (LDTs)](https://www.rqmplus.com/blog/ensuring-compliance-with-fdas-final-rule-for-laboratory-developed-tests-ldts/)
- [Europe, the EU, and the EU Single Market: geopolitical implications for MedTech](https://www.rqmplus.com/blog/europe-the-eu-and-the-eu-single-market-geopolitical-implications-for-medtech/)
- [Exploring Clinical Trials Services for Alzheimer’s Diagnostics and Clinical Deployment](https://www.rqmplus.com/blog/alzheimers-diagnostic-clinical-trial-services/)
- [Exploring the Importance of Polymer Analysis](https://www.rqmplus.com/blog/exploring-the-importance-of-polymer-analysis/)
- [FDA Friday: Reclassification](https://www.rqmplus.com/blog/fda-friday-reclassification/)
- [FDA Inspections Database](https://www.rqmplus.com/blog/2013-06-fda-inspections-database/)
- [FDA Proposed Rule: Impact on Wound Care Devices](https://www.rqmplus.com/blog/fda-proposed-rule-impact-on-wound-care-devices/)
- [Finding Clinical Trial Support for Different Therapeutic Areas](https://www.rqmplus.com/blog/finding-clinical-trial-support-therapeutic-areas/)
- [Future-Proofing Sterilization: Understanding EPA's New EtO Standards and What To Do Now](https://www.rqmplus.com/blog/future-proofing-sterilization-understanding-epas-new-eto-standards-and-what-to-do-now/)
- [Global Perspectives: Comparing Regulations for Point of Care Tests in the U.S. and EU](https://www.rqmplus.com/blog/global-perspectives-comparing-regulations-for-point-of-care-tests-in-the-u-s-and-eu/)
- [Good Manufacturing Practice in the Medical Device Industry](https://www.rqmplus.com/blog/good-manufacturing-practice-medical-device-industry/)
- [Greenlit in Europe, Grounded in America: A Medtech Paradox](https://www.rqmplus.com/blog/greenlit-in-europe-grounded-in-america-a-medtech-paradox/)
- [Hearts in a Bind: Choosing Between Promise and Predictability](https://www.rqmplus.com/blog/hearts-in-a-bind-choosing-between-promise-and-predictability-tavr/)
- [How a Full-Service CRO Can Get Your Device to Market Quicker](https://www.rqmplus.com/blog/how-a-full-service-cro-can-get-your-device-to-market-quicker/)
- [How is MedTech Transforming Breast Cancer Care?](https://www.rqmplus.com/blog/how-is-medtech-transforming-breast-cancer-care/)
- [How Polymer Testing Helps Medical Device Manufacturers Prevent Material Failures](https://www.rqmplus.com/blog/polymer-testing-medical-device-failures/)
- [How to Choose a GPC Column](https://www.rqmplus.com/blog/how-to-choose-gpc-column/)
- [How to Choose the Best Fit PMCF Strategy: Full-Scale PMCF Trial vs. PMCF Survey](https://www.rqmplus.com/blog/choose-best-pmcf-strategy-trial-vs-survey/)
- [How to Develop a Biological Evaluation Plan](https://www.rqmplus.com/blog/how-develoo-biological-evaluation-plan/)
- [How to Navigate SaMD Regulatory Pathways: From FDA to EU MDR & IMDRF](https://www.rqmplus.com/blog/samd-regulatory-pathways-fda-eu-mdr-imdrf/)
- [How to Obtain CE Marking Under the IVDR](https://www.rqmplus.com/blog/ce-marking-under-the-ivdr/)
- [How to Obtain CE Marking Under the MDR](https://www.rqmplus.com/blog/ce-marking-under-the-mdr/)
- [How to Prepare a Design History File for FDA Inspection](https://www.rqmplus.com/blog/how-to-prepare-a-design-history-file-for-fda-inspection/)
- [How to Submit FDA CDRH Submissions Online](https://www.rqmplus.com/blog/how-to-submit-fda-cdrh-submissions-online/)
- [Impact of FDA's Final LDT Rule: Industry Concerns and Compliance](https://www.rqmplus.com/blog/impact-of-fdas-final-ldt-rule-industry-concerns-and-compliance/)
- [Inside a Hybrid Partnership: How Jordi Labs Supports MedTech Teams with On-Demand Expertise](https://www.rqmplus.com/blog/hybrid-partnership-jordi-labs-medtech-expertise/)
- [Insight into RQM+ Consultation: How the Most Appropriate Study Design is Determined](https://www.rqmplus.com/blog/insight-into-rqm-consultation-how-the-most-appropriate-study-design-is-determined/)
- [Intended Use: Foundation stone, guiding light or just a box to tick?](https://www.rqmplus.com/blog/intended-use/)
- [ISO 10993-1 6th Edition is Here – Are You Ready?](https://www.rqmplus.com/blog/iso-10993-1-6th-edition-is-here-are-you-ready/)
- [ISO 10993-18 Is Changing. Here’s What MedTech Teams Keep Getting Wrong](https://www.rqmplus.com/blog/iso-10993-18-is-changing/)
- [ISO 14971: 2019: 3 Key Changes from ISO 14971: 2007](https://www.rqmplus.com/blog/key-changes-from-iso-149712019-from-iso-149712007/)
- [Join Live Webinar: Decoding MDCG 2023-7 for MedTech Devices](https://www.rqmplus.com/blog/join-live-webinar-decoding-mdcg-2023-7-for-medtech-devices/)
- [Key Benefits of Chemical Characterization Laboratory Services](https://www.rqmplus.com/blog/key-benefits-of-chemical-characterization-laboratory-services/)
- [Laboratory Developed Tests: Current State of Play FAQ](https://www.rqmplus.com/blog/laboratory-developed-tests-current-state-of-play-faq/)
- [Latex and DEHP and BPA, Oh my!](https://www.rqmplus.com/blog/2013-03-latex-and-dehp-and-bpa-oh-my/)
- [Let's Talk About Women's Health: Diabetes](https://www.rqmplus.com/blog/lets-talk-about-womens-health-diabetes/)
- [Let's Talk About Women's Health: Thyroid Dysfunction](https://www.rqmplus.com/blog/lets-talk-about-womens-health-thyroid-dysfunction/)
- [Mastering the Transition: 5 Essential Tips for EU MDR Compliance](https://www.rqmplus.com/blog/mastering-the-transition-5-essential-tips-for-eu-mdr-compliance/)
- [Med Device Monday - Luminopia One, A Digital Therapeutic to Help Treat Amblyopia](https://www.rqmplus.com/blog/med-device-monday-luminopia-one/)
- [Med Device Monday: Bone Anchors](https://www.rqmplus.com/blog/med-device-monday-bone-anchors/)
- [Med Device Monday: Briteseed and SafeSnips](https://www.rqmplus.com/blog/med-device-monday-briteseed-and-safesnips/)
- [Med Device Monday: C-Section Retractor](https://www.rqmplus.com/blog/med-device-monday-c-section-retractor/)
- [Med Device Monday: Nonabsorbent Dressing](https://www.rqmplus.com/blog/med-device-monday-nonabsorbent-dressing/)
- [Med Device Monday: Restless Leg Relaxer](https://www.rqmplus.com/blog/med-device-monday-restless-leg-syndrome-treatment/)
- [Medical Devices, IVDs and Other EU Laws](https://www.rqmplus.com/blog/medical-devices-ivds-and-other-eu-laws/)
- [MitraClip and the Business of American Healthcare: Innovation, Inefficiency, and the Cost of Care](https://www.rqmplus.com/blog/mitraclip-and-the-business-of-american-healthcare-innovation-inefficiency-and-the-cost-of-care/)
- [Molecular Weight Analysis: How to Measure MW?](https://www.rqmplus.com/blog/molecular-weight-analysis-how-to/)
- [Musical Chairs MDR-Style: Keep Dancing Even Though the Music Has Stopped](https://www.rqmplus.com/blog/musical-chairs-mdr-style-keep-dancing-even-though-the-music-has-stopped/)
- [Nancy Morrison's Keys to Thriving in Regulatory Affairs: Lessons Learned from a 30+ Year Career](https://www.rqmplus.com/blog/nancy-morrisons-keys-to-thriving-in-regulatory-affairs-lessons-learned-from-a-30-year-career/)
- [Navigating PFAS Regulations: Lab Analysis for Medical Device Material Changes](https://www.rqmplus.com/blog/navigating-pfas-regulations-lab-analysis-for-medical-device-material-changes/)
- [New FDA Dataset Marks a Transformative Leap for Chemical Characterization](https://www.rqmplus.com/blog/new-fda-dataset-marks-a-transformative-leap-for-chemical-characterization/)
- [New Guidance: FDA Safer Technologies Program (STeP) for Medical Devices](https://www.rqmplus.com/blog/fda-step-guidance/)
- [One Year Countdown: Preparing for the FDA's QMSR Implementation](https://www.rqmplus.com/blog/one-year-countdown-preparing-for-the-fdas-qmsr-implementation/)
- [Opportunity & Risk: Why we should open our minds to off-label use](https://www.rqmplus.com/blog/opportunity-risk-why-we-should-open-our-minds-to-off-label-use/)
- [Overcoming Pain-Points in MedTech Clinical Trials for Brain Health Devices](https://www.rqmplus.com/blog/brain-health-medtech-clinical-trial-challenges/)
- [Polymer Failure Analysis with Jordi Labs, an RQM+ Company](https://www.rqmplus.com/blog/polymer-failure-analysis-with-jordi-labs-an-rqm-company/)
- [Preparing for the Phase-Out of PFAS in MedTech Manufacturing](https://www.rqmplus.com/blog/preparing-for-the-phase-out-of-pfas-in-medtech-manufacturing/)
- [Product Deformulation: A Step-by-Step Guide to Reverse Engineering](https://www.rqmplus.com/blog/product-deformulation-guide-reverse-engineering/)
- [Product Deformulation: Reverse Engineering with RQM+ Lab Services](https://www.rqmplus.com/blog/product-deformulation-reverse-engineering/)
- [Protein Characterization, Identification & Purification](https://www.rqmplus.com/blog/protein-characterization-identification-purification/)
- [Quick Guide to Medical Device Standards: ISO Standards and Beyond](https://www.rqmplus.com/blog/quick-guide-to-medical-device-standards-iso-standards-and-beyond-rqm/)
- [R&Q Acquires Maetrics to Form the Largest Medical Device-Focused Regulatory and Quality Consultancy](https://www.rqmplus.com/blog/randq-acquires-maetrics/)
- [Recent Developments in EU Horizontal Legislation](https://www.rqmplus.com/blog/recent-developments-in-eu-horizontal-legislation/)
- [Redefining HFpEF Care: Precision Therapies for an Inclusive Future](https://www.rqmplus.com/blog/redefining-hfpef-care-precision-therapies-for-an-inclusive-future/)
- [SaMD vs. SiMD: What You Must Know for Accurate Classification](https://www.rqmplus.com/blog/samd-vs-simd-what-you-must-know-for-accurate-classification/)
- [Stick or Twist? 2025 Is a Big Year for ISO 13485](https://www.rqmplus.com/blog/stick-or-twist-2025-is-a-big-year-for-iso-13485/)
- [Streamlining AE Reporting in PMCF Studies (FDA Perspective)](https://www.rqmplus.com/blog/streamlining-ae-reporting-in-pmcf-studies-fda-perspective/)
- [Structured Dialogue: A Key to Efficient Regulatory Compliance in the EU](https://www.rqmplus.com/blog/structured-dialogue-a-key-to-efficient-regulatory-compliance-in-the-eu/)
- [Summary of FDA Regulatory Changes for Digital Health Devices in Q3 2022](https://www.rqmplus.com/blog/summary-of-fda-regulatory-changes-for-digital-health-devices/)
- [Ten Tips for A Successful Use of Total Product Life Cycle (TPLC) Reports](https://www.rqmplus.com/blog/2014-06-ten-tips-successful-use-total-product-life-cycle-tplc-reports/)
- [The Basics of Polymer Analysis: Techniques & Solutions](https://www.rqmplus.com/blog/basics-polymer-analysis-techniques-solutions/)
- [The Courage to Say No: Boston Scientific Does What the CE Mark Didn’t](https://www.rqmplus.com/blog/the-courage-to-say-no-boston-scientific-does-what-the-ce-mark-didnt/)
- [The de novo Pathway: Is It Right for My Device?](https://www.rqmplus.com/blog/the-de-novo-pathway-is-it-right-for-my-device/)
- [The German DiGA Idea: Revolutionizing Health Care with Digital Health Applications](https://www.rqmplus.com/blog/the-german-diga-idea-revolutionizing-health-care-with-digital-health-applications/)
- [The Most Common Issues Affecting Biocompatibility Tests](https://www.rqmplus.com/blog/the-most-common-issues-affecting-biocompatibility-tests/)
- [The New Human Factors Playbook: Why Your Combo Device Submission is Depending on It](https://www.rqmplus.com/blog/the-new-human-factors-playbook-why-your-combo-device-submission-is-depending-on-it/)
- [The Road to Remediation: Ensuring Quality, Safety, and Compliance in MedTech](https://www.rqmplus.com/blog/the-road-to-remediation-ensuring-quality-safety-and-compliance-in-medtech/)
- [The Working Principles of Dynamic Light Scattering](https://www.rqmplus.com/blog/the-working-principles-of-dynamic-light-scattering/)
- [The Working Principles of Gel Permeation Chromatography](https://www.rqmplus.com/blog/principles-gel-permeation-chromatography/)
- [Three Critical Aspects of Analytical Testing for Pharmaceuticals](https://www.rqmplus.com/blog/three-critical-aspects-of-analytical-testing-for-pharmaceuticals/)
- [Three for the Price of One: The Latest Amendments to the MDR & IVDR Have Arrived](https://www.rqmplus.com/blog/three-for-the-price-of-one-the-latest-amendments-to-the-mdr-ivdr-have-arrived/)
- [Titrimetry: A Brief Overview](https://www.rqmplus.com/blog/titrimetry-brief-overview/)
- [Transhumanism - Science from Fiction: Part I - Bionic Body Parts](https://www.rqmplus.com/blog/2013-10-transhumanism-science-fiction-part-bionic-body-parts/)
- [Tricuspid Brinkmanship: Are We Overhyping the Right-Sided Revolution?](https://www.rqmplus.com/blog/tricuspid-brinkmanship-are-we-overhyping-the-right-sided-revolution/)
- [Tricuspid Regurgitation: State-of-the-Art Insights](https://www.rqmplus.com/blog/tricuspid-regurgitation-state-of-the-art-insights/)
- [Typical Molecular Weights of Common Polymers](https://www.rqmplus.com/blog/typical-polymer-molecular-weights/)
- [Unbiased Outcomes: The Challenges of Equity in MedTech](https://www.rqmplus.com/blog/unbiased-outcomes-the-challenges-of-equity-in-medtech/)
- [Understanding Extractables and Leachables](https://www.rqmplus.com/blog/understanding-extractables-leachables-pharmaceutical-products/)
- [Unveiling MDCG 2023-7: Equivalence, Clinical Investigations and Data Access Under EU MDR](https://www.rqmplus.com/blog/unveiling-mdcg-2023-7-equivalence-clinical-investigations-and-data-access-under-eu-mdr/)
- [Validating the Future of Neuromodulation: How Jordi Labs Supports Regulatory-Ready Innovation](https://www.rqmplus.com/blog/validating-neuromodulation-jordi-labs-regulatory-support/)
- [We Make Women's Health Happen: Innovative Devices for Fertility Treatment](https://www.rqmplus.com/blog/we-make-womens-health-happen-innovative-devices-for-fertility-treatment/)
- [What Are Clinical Benefits and How Do You Evaluate Them in Your CER?](https://www.rqmplus.com/blog/what-are-clinical-benefits-and-how-do-you-evaluate-them-in-your-cer/)
- [What are the Key Clinical Trial Therapeutic Areas?](https://www.rqmplus.com/blog/what-are-the-key-clinical-trial-therapeutic-areas/)
- [What Can You Gain From Full-Service MedTech Consulting?](https://www.rqmplus.com/blog/full-service-medtech-consulting-benefits/)
- [What GMP Means in Pharma](https://www.rqmplus.com/blog/what-gmp-pharma/)
- [What Is a Contract Research Organization (CRO)?](https://www.rqmplus.com/blog/contract-research-organization-cro/)
- [What is Elemental Analysis Used For?](https://www.rqmplus.com/blog/what-elemental-analysis-used-for/)
- [What is Polymer Material Performance Testing?](https://www.rqmplus.com/blog/polymer-material-performance-testing-medical-devices/)
- [What is Polymer Molecular Weight?](https://www.rqmplus.com/blog/what-is-polymer-molecular-weight/)
- [What is the Benefit of Seeing the Brain?](https://www.rqmplus.com/blog/what-is-the-benefit-of-seeing-the-brain/)
- [What is Thermal Gravimetric Analysis?](https://www.rqmplus.com/blog/what-is-thermal-gravimetric-analysis/)
- [What is Transmission Electron Microscopy?](https://www.rqmplus.com/blog/what-is-transmission-electron-microscopy/)
- [Where can your CE mark take you next?](https://www.rqmplus.com/blog/where-can-your-ce-mark-take-you-next/)
- [Why Agile Staffing Is Essential for Regulatory-Heavy MedTech Projects](https://www.rqmplus.com/blog/agile-staffing-regulatory-medtech-projects/)
- [Why You Should Verify Your Supplier's MedTech Materials](https://www.rqmplus.com/blog/why-you-should-verify-your-suppliers-medtech-materials/)
- [Why You Still Need Medical Writers in the Age of AI](https://www.rqmplus.com/blog/why-medical-writers-still-matter-ai/)
- [Wires to AI: The Regulatory Landscape of Neurological Devices](https://www.rqmplus.com/blog/ai-regulatory-landscape-of-neurological-devices/)

### Pages

- [About Us](https://www.rqmplus.com/about-us/)
- [Blog](https://www.rqmplus.com/blog/)
- [Candidate Privacy Statement](https://www.rqmplus.com/candidate-privacy-statement/)
- [Careers](https://www.rqmplus.com/about-us/careers/)
- [Chemical & Cosmetic](https://www.rqmplus.com/solutions/lab-services/chemical-cosmetic/)
- [Client Privacy Statement](https://www.rqmplus.com/client-privacy-statement/)
- [Clinical Trials](https://www.rqmplus.com/solutions/clinical-trials/)
- [Coding & Billing](https://www.rqmplus.com/solutions/reimbursement/coding-billing/)
- [Combination Products](https://www.rqmplus.com/expertise/combination-products/)
- [Companion Diagnostics (CDx)](https://www.rqmplus.com/expertise/companion-diagnostics-cdx/)
- [Cookies Policy](https://www.rqmplus.com/cookies-policy/)
- [Emerging MedTech & Startups](https://www.rqmplus.com/emerging-medtech-companies/)
- [Events](https://www.rqmplus.com/about-us/news-events/events/)
- [Expertise](https://www.rqmplus.com/expertise/)
- [Full Site Map](https://www.rqmplus.com/full-site-map-36/)
- [Health Economics](https://www.rqmplus.com/solutions/reimbursement/health-economics/)
- [Home](https://www.rqmplus.com/)
- [In Vitro Diagnostics](https://www.rqmplus.com/expertise/ivd/)
- [Lab & Material Science](https://www.rqmplus.com/solutions/lab-services/)
- [Leadership](https://www.rqmplus.com/about-us/leadership/)
- [Make MedTech Happen](https://www.rqmplus.com/make-medtech-happen/)
- [Market Access Roadmap](https://www.rqmplus.com/solutions/reimbursement/market-access-roadmap/)
- [Match with a Contractor](https://www.rqmplus.com/match-with-a-contractor/)
- [Med Device](https://www.rqmplus.com/expertise/med-device/)
- [Media Inquiries](https://www.rqmplus.com/about-us/media-inquiries/)
- [Medical Device](https://www.rqmplus.com/solutions/lab-services/medical-device/)
- [Medical Devices](https://www.rqmplus.com/expertise/medical-devices/)
- [New Product Development](https://www.rqmplus.com/solutions/regulatory-quality/new-product-development/)
- [News](https://www.rqmplus.com/about-us/news-events/news/)
- [News & Events](https://www.rqmplus.com/about-us/news-events/)
- [Order an Audit](https://www.rqmplus.com/order-an-audit/)
- [Partner with Us](https://www.rqmplus.com/contact/)
- [Payer Research & Gap Analysis](https://www.rqmplus.com/solutions/reimbursement/payer-research-gap-analysis/)
- [Pharmaceutical](https://www.rqmplus.com/solutions/lab-services/pharmaceutical/)
- [Pilot Studies](https://www.rqmplus.com/solutions/clinical-trials/pilot-studies/)
- [Pivotal Studies](https://www.rqmplus.com/solutions/clinical-trials/pivotal-studies/)
- [Please confirm your opt in below!](https://www.rqmplus.com/please-confirm-your-opt-in-below/)
- [Privacy Notice](https://www.rqmplus.com/privacy-notice/)
- [Regulatory & Quality](https://www.rqmplus.com/solutions/regulatory-quality/)
- [Reimbursement​](https://www.rqmplus.com/solutions/reimbursement/)
- [Remediation](https://www.rqmplus.com/solutions/regulatory-quality/remediation/)
- [Remediation Studies](https://www.rqmplus.com/solutions/clinical-trials/remediation-studies/)
- [Resource Library](https://www.rqmplus.com/resources/)
- [RQM+ Acting as a Data Processor (Privacy Notice Addendum)](https://www.rqmplus.com/privacy-notice/data-processor/)
- [RQM+ Daily](https://www.rqmplus.com/rqm-daily/)
- [RQM+ is The MedTech CRO](https://www.rqmplus.com/the-medtech-cro/)
- [Social Icons](https://www.rqmplus.com/social-icons-39/)
- [Software-Enabled Products](https://www.rqmplus.com/expertise/software-enabled-products/)
- [Solutions](https://www.rqmplus.com/solutions/)
- [Strategy Development](https://www.rqmplus.com/solutions/reimbursement/strategy-development/)
- [Sustaining](https://www.rqmplus.com/solutions/regulatory-quality/sustaining/)
- [Thank you for opting in!](https://www.rqmplus.com/thank-you-for-opting-in/)
- [Thank you for scanning!](https://www.rqmplus.com/thank-you-for-scanning-clinical-trials-white-papers/)
- [Thank you for scanning!](https://www.rqmplus.com/thank-you-for-scanning/)
- [Thank you! Here are your white papers.](https://www.rqmplus.com/thank-you-here-are-your-white-papers/)

### Events

- [14th Annual Outsourcing in Clinical Trials: Medical Devices Europe 2026](https://www.arena-international.com/event/octmedeurope/)
- [2025 Regulatory Intelligence Conference Europe](https://web.cvent.com/event/d01c990b-e311-4132-8308-0ae96f185de7/summary?utm_campaign=11124480-partner_events_2025_mtaa&utm_medium=email&_hsmi=2&utm_content=2&utm_source=hs_email)
- [2025 UK MDR Regulatory Conference](https://web.cvent.com/event/0d338e59-28be-47b0-930b-9dc6d7c0e4eb/summary?utm_campaign=11124480-partner_events_2025_mtaa&utm_medium=email&_hsmi=2&utm_content=2&utm_source=hs_email)
- [ADLM 2025](https://www.rqmplus.com/about-us/news-events/events/adlm-2025/)
- [American Medical Device Summit 2025](https://amdsummit.com/)
- [CSMD-Horizon Special Conference for Medtech AI and Digital Health](https://csmd-horizon.com/)
- [DeviceTalks Boston 2025](https://www.rqmplus.com/about-us/news-events/events/devicetalks-boston-2025/)
- [Extractables & Leachables West 2025](https://www.pharmaedresources.com/event/extractables-leachables-summit-2025/)
- [Global Regulatory Strategy Conference](https://www.rqmplus.com/about-us/news-events/events/global-regulatory-strategy-conference/)
- [LSI Emerging MedTech Summit USA 2025](https://www.rqmplus.com/about-us/news-events/events/lsi-emerging-medtech-summit-usa-2025/)
- [LSI Europe '25 Emerging Medtech Summit](https://www.lsieuropesummit.com/)
- [LSI USA '26 Emerging MedTech Summit](https://www.lsiusasummit.com/)
- [MD&M East 2025](https://www.rqmplus.com/about-us/news-events/events/mdm-east-2025/)
- [MedTech Summit 2025](https://www.rqmplus.com/about-us/news-events/events/medtech-summit-2025/)
- [Outsourcing in Clinical Trials: Medical Devices USA 2025](https://www.rqmplus.com/about-us/news-events/events/outsourcing-in-clinical-trials-medical-devices-usa-2025/)
- [PharmaEd Combination Products Summit 2025](https://www.rqmplus.com/about-us/news-events/events/pharmaed-combination-products-summit-2025/)
- [RAPS Convergence 2025](https://www.raps.org/convergence-2024/recap)
- [RAPS Euro Convergence 2025](https://www.rqmplus.com/about-us/news-events/events/raps-euro-convergence-2025/)
- [RAPS Euro Convergence 2026](https://www.raps.org/europe-2025/home)
- [RAPS Global Regulatory Strategy Conference](https://grs2026.eventscribe.net/)
- [RQM+ Webinar – Bridging the Real-World Evidence Gap](https://www.rqmplus.com/resources/bridging-the-real-world-evidence-gap/)
- [Smithers Extractables & Leachables U.S.A. 2025](https://www.rqmplus.com/about-us/news-events/events/smithers-extractables-leachables-u-s-a-2025/)
- [SOT 64th Annual Meeting and ToxExpo](https://www.rqmplus.com/about-us/news-events/events/sot-64th-annual-meeting-and-toxexpo/)
- [The MedTech Conference, hosted by AdvaMed](https://themedtechconference.com/)
- [Webinar – QMSR is Coming: How to Prepare for FDA’s Alignment with ISO 13485](https://www.rqmplus.com/about-us/news-events/events/webinar-qmsr-is-coming-how-to-prepare-for-fdas-alignment-with-iso-13485/)
- [Webinar: RWE for Orphan Devices Under New EU Guidance & Beyond](https://www.rqmplus.com/about-us/news-events/events/webinar-rwe-for-orphan-devices-under-new-eu-guidance-beyond/)
- [World Health Expo](https://www.worldhealthexpo.com/events/healthcare/dubai/en/home.html)

### News

- [3Aware and RQM+ Forge Partnership to Enhance MedTech Compliance and Innovation](https://www.rqmplus.com/about-us/news-events/news/3aware-and-rqm-forge-partnership-to-enhance-medtech-compliance-and-innovation/)
- [John Potthoff Joins RQM+™ as CEO](https://www.rqmplus.com/about-us/news-events/news/john-potthoff-joins-rqm-as-ceo/)
- [Leadership Appointments at RQM+](https://www.rqmplus.com/about-us/news-events/news/leadership-appointments-at-rqm/)
- [RQM+ Appoints Ross D. Segan, MD, MBA, FACS, to Board of Directors](https://www.rqmplus.com/about-us/news-events/news/rqm-appoints-ross-d-segan-md-mba-facs-to-board-of-directors/)
- [RQM+ Launches SMART Solutions Life Cycle Partnership Model](https://www.rqmplus.com/about-us/news-events/news/rqm-launches-smart-solutions-life-cycle-partnership-model/)
- [RQM+™ Launches Fern.ai™ Smart Authoring Module for MedTech](https://www.rqmplus.com/about-us/news-events/news/rqm-launches-fern-ai-smart-authoring-module-for-medtech/)
- [We Don’t Make MedTech — We Make MedTech Happen: Introducing the New RQM+ Brand Identity](https://www.rqmplus.com/about-us/news-events/news/we-dont-make-medtech-we-make-medtech-happen-introducing-the-new-rqm-brand-identity/)

### Resource

- [7 Reimbursement Strategy Gaps Your MedTech Needs to Bridge](https://www.rqmplus.com/resources/7-reimbursement-strategy-gaps-your-medtech-needs-to-bridge/)
- [A Guide to Smarter E&L Testing & ISO 10993-18 Compliance](https://www.rqmplus.com/resources/el-testing-iso-10993-18/)
- [A New Era of LDT Oversight: Adapting to FDA Regulations](https://www.rqmplus.com/resources/a-new-era-of-ldt-oversight-adapting-to-fda-regulations/)
- [Adapting to the New LDT Regulatory Reality](https://www.rqmplus.com/resources/adapting-to-the-new-ldt-regulatory-reality/)
- [Advancing Health Equity with IVDs & Medical Devices](https://www.rqmplus.com/resources/advancing-health-equity-with-ivds-medical-devices/)
- [AI in Medical Devices: Practical Adoption for Medical Device Regulatory Teams](https://www.rqmplus.com/resources/ai-in-medical-devices-practical-adoption-for-medical-device-regulatory-teams/)
- [AI Meets Regulation](https://www.rqmplus.com/resources/upcoming-event-on-october-30-ai-meets-regulation/)
- [Aligning Your QMS with the FDA's QMSR Updates](https://www.rqmplus.com/resources/aligning-your-qms-with-the-fdas-qmsr-updates/)
- [Answering the Tough Questions: What Innovators Really Want to Know About Partnering With a Specialized MedTech CRO](https://www.rqmplus.com/resources/answering-the-tough-questions-what-innovators-really-want-to-know-about-partnering-with-a-specialized-medtech-cro/)
- [Are We Equipped to Handle a PFAS-Free Future?](https://www.rqmplus.com/resources/are-we-equipped-to-handle-a-pfas-free-future/)
- [Behind the Scenes with BSI Head of IVD Notified Body, Alex Laan](https://www.rqmplus.com/resources/behind-the-scenes-with-bsi-head-of-ivd-notified-body-alex-laan/)
- [Beyond EtO: New EPA Regulations and Sterilization Alternatives](https://www.rqmplus.com/resources/beyond-eto-new-epa-regulations-and-sterilization-alternatives/)
- [Beyond Indications: Managing Off-Label Use for Safety and Compliance](https://www.rqmplus.com/resources/beyond-indications-managing-off-label-use-for-safety-and-compliance/)
- [Bridging the Real-World Evidence Gap](https://www.rqmplus.com/resources/bridging-the-real-world-evidence-gap/)
- [Built for Her: Funding, Fixing, and Fueling the Next Era of MedTech](https://www.rqmplus.com/resources/built-for-her/)
- [Case Study: Rescuing a Stalled IDE Submission via Advanced Chemical Characterization](https://www.rqmplus.com/resources/case-study-rescuing-a-stalled-ide-submission-via-advanced-chemical-characterization/)
- [Case Study: RQM+ Partners With Global IVD Manufacturer to Remediate Over 150 IVDR Technical Files](https://www.rqmplus.com/resources/case-study-rqm-partners-with-global-ivd-manufacturer-to-remediate-over-150-ivdr-technical-files/)
- [Compliance for EU Market Access](https://www.rqmplus.com/resources/upcoming-event-on-september-18-rqm-live-89-compliance-for-eu-market-access/)
- [Critical Shifts in Biological Evaluation: Inside the New ISO 10993-1 Risk Management Framework](https://www.rqmplus.com/resources/rsvp-live-84-critical-shifts-in-biological-evaluation/)
- [Electric Brains & Regulatory Pains: Accelerate Neurology Innovation, Slash Risk, & Win Approval](https://www.rqmplus.com/resources/electric-brains-regulatory-pains-accelerate-neurology-innovation-slash-risk-win-approval/)
- [Enhancing Accuracy in E&L Testing With Machine Learning: Response Factor Prediction for Smarter Decisions](https://www.rqmplus.com/resources/enhancing-accuracy-in-el-testing-with-machine-learning-response-factor-prediction-for-smarter-decisions/)
- [EU MDR Timelines and Fine Lines: Unraveling Critical Transition Nuances to Gain Compliance](https://www.rqmplus.com/resources/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance/)
- [Exiting PFAS: A Strategic Blueprint for Medical Device Manufacturers](https://www.rqmplus.com/resources/exiting-pfas-a-strategic-blueprint-for-medical-device-manufacturers/)
- [FDA's Wound Care Shakeup: Ensuring Your Products Make the Cut](https://www.rqmplus.com/resources/rsvp-live-79-fda-wound-care-shakeup/)
- [From Crisis to Competitive Advantage: A Strategic Guide to the FDA Warning Letter Response](https://www.rqmplus.com/resources/from-crisis-to-competitive-advantage-a-strategic-guide-to-the-fda-warning-letter-response/)
- [Get Ahead of the Crisis: How Your Quality System Can Prevent Negative Impacts on Customers, Patients, and Reputation](https://www.rqmplus.com/resources/get-ahead-of-the-crisis/)
- [How AI is Revolutionizing MedTech: Current and Future Applications](https://www.rqmplus.com/resources/how-ai-is-revolutionizing-medtech-current-and-future-applications/)
- [Insider Perspectives: Mastering EU Compliance with BSI's Richard Holborow and RQM+'s Amie Smirthwaite](https://www.rqmplus.com/resources/insider-perspectives-mastering-eu-compliance-with-bsis-richard-holborow-and-rqms-amie-smirthwaite/)
- [Is Your E&L Testing Strategy Future-Ready?](https://www.rqmplus.com/resources/is-your-el-testing-strategy-future-ready/)
- [IVDR Class D Devices: Advanced Strategies for Succeeding In a Dynamic Regulatory Environment](https://www.rqmplus.com/resources/ivdr-class-d-devices-advanced-strategies-for-succeeding-in-a-dynamic-regulatory-environment/)
- [Jordi Labs’ Lumo: Accurate Response Factors that Strengthen TRA and E&L Decisions](https://www.rqmplus.com/resources/jordi-labs-lumo-accurate-response-factors-that-strengthen-tra-and-el-decisions/)
- [Lumo™: AI-Powered Response Factor Prediction for E&L](https://www.rqmplus.com/resources/lumo-ai-powered-response-factor-prediction-for-el/)
- [Material Matters: Navigating Risks and Strategies for Improving Medical Device Safety](https://www.rqmplus.com/resources/material-matters-navigating-risks-and-strategies-for-improving-medical-device-safety/)
- [MDCG 2023-7: New Clinical Evidence Pathways for Legacy and New Devices](https://www.rqmplus.com/resources/mdcg-2023-7/)
- [MDR and IVDR Amendments:Strategies for Supply Interruption Compliance](https://www.rqmplus.com/resources/mdr-ivdr-amendments/)
- [Modernizing MedTech Research via Hybrid Study Approaches to Enhance Your Patient Recruitment](https://www.rqmplus.com/resources/modernizing-medtech-research-via-hybrid-study-approaches-to-enhance-your-patient-recruitment/)
- [Neural Network Response Factor Prediction for E&L](https://www.rqmplus.com/resources/neural-network-response-factor-prediction-for-el/)
- [Neurons on Fire: The MedTech Revolution You Can't Afford to Miss](https://www.rqmplus.com/resources/neurons-on-fire-the-medtech-revolution-you-cant-afford-to-miss/)
- [October Overview: Essential Insights from an Eventful Month in MedTech](https://www.rqmplus.com/resources/october-overview-essential-insights-from-an-eventful-month-in-medtech/)
- [PART 1: Medical Device Cybersecurity: Proven Strategies for Connected Devices and SaMD](https://www.rqmplus.com/resources/part-1-medical-device-cybersecurity-proven-strategies-for-connected-devices-and-samd/)
- [PART 2: Medical Device Cybersecurity: Proven Strategies for Connected Devices and SaMD](https://www.rqmplus.com/resources/med-device-cybersecurity-part-2/)
- [PMCF Surveys That Survive Scrutiny](https://www.rqmplus.com/resources/upcoming-event-on-october-2-rqm-live-90-pmcf-surveys-that-survive-scrutiny/)
- [Practical Points in Creating Clinical Evidence for AI SaMD Medical Devices](https://www.rqmplus.com/resources/practical-points-in-creating-clinical-evidence-for-ai-samd-medical-devices/)
- [Pragmatic and Compliant Approaches to Clinical Evidence](https://www.rqmplus.com/resources/pragmatic-and-compliant-approaches-to-clinical-evidence/)
- [Pre-Submission to Preeminence: Showcasing FDA's Latest Pre-Sub Guidance and Uncovering PCCP Best Practices](https://www.rqmplus.com/resources/pre-submission-to-preeminence-showcasing-fdas-latest-pre-sub-guidance-and-uncovering-pccp-best-practices/)
- [Shattering Barriers: Advancing Healthcare Equity by Enhancing Diversity in Clinical Trials for a Future of Inclusive Innovation](https://www.rqmplus.com/resources/advancing-healthcare-equity/)
- [Start 2023 Right: Smart and Savvy Tips from Former Regulators and Notified Bodies](https://www.rqmplus.com/resources/start-2023-right-smart-and-savvy-tips-from-former-regulators-and-notified-bodies/)
- [Structured Dialogue: How to Engage with Notified Bodies](https://www.rqmplus.com/resources/structured-dialogue-how-to-engage-with-notified-bodies/)
- [The Business Case for Outsourcing Medical Device Product Life Cycle Management ](https://www.rqmplus.com/resources/the-business-case-for-outsourcing-medical-device-product-life-cycle-management/)
- [The Evolving Biocompatibility Landscape: Staying Ahead of Regulatory Requirements](https://www.rqmplus.com/resources/the-evolving-biocompatibility-landscape-staying-ahead-of-regulatory-requirements/)
- [The German DiGA Idea: Revolutionizing Healthcare with Digital Health Applications](https://www.rqmplus.com/resources/the-german-diga-idea/)
- [The Investigative Science of Smart Cardiac Implants: Securing Compliance Through Complex Chemical Characterization](https://www.rqmplus.com/resources/the-investigative-science-of-smart-cardiac-implants-securing-compliance-through-complex-chemical-characterization/)
- [The MedTech Life Cycle Management Outsourcing Tool Kit](https://www.rqmplus.com/resources/the-medtech-life-cycle-management-outsourcing-tool-kit/)
- [The Predictive E&L Blueprint](https://www.rqmplus.com/resources/the-predictive-el-blueprint/)
- [The Real Cost of Noncompliance: Leveraging IVDR for Long-Term Savings](https://www.rqmplus.com/resources/rqmplus-white-paper-ithe-real-cost-of-noncompliance-ivdr/)
- [The Review-Reducing PMCF Survey Checklist](https://www.rqmplus.com/resources/the-review-reducing-pmcf-survey-checklist/)
- [The Ultimate Medical Device Internal Audit Tool Kit ](https://www.rqmplus.com/resources/the-ultimate-medical-device-internal-audit-tool-kit/)
- [Transforming Your Risk-Based Monitoring Strategy: The Era of AI, Sensors, and Hybrid Trials](https://www.rqmplus.com/resources/transforming-your-risk-based-monitoring-strategy-the-era-of-ai-sensors-and-hybrid-trials/)
- [Trials That Pay: Designing Clinical Studies to Optimize Reimbursement and Market Access](https://www.rqmplus.com/resources/trials-that-pay/)
- [We Need to Talk About Risk: The Critical Role of Communication in Risk Management](https://www.rqmplus.com/resources/we-need-to-talk-about-risk-the-critical-role-of-communication-in-risk-management/)
- [When Regulatory Strategy Becomes a Commercial Advantage](https://www.rqmplus.com/resources/when-regulatory-strategy-becomes-a-commercial-advantage/)
- [Women’s Health MedTech Innovators: Are You Prepared for These 6 Regulatory Strategy and Market Access Hurdles?](https://www.rqmplus.com/resources/womens-health-medtech-innovators-are-you-prepared-for-these-6-regulatory-strategy-and-market-access-hurdles/)

### Leadership

- [Kevin Rowland](https://www.rqmplus.com/about/team/kevin-rowland/)
- [Jaishankar Kutty, PhD](https://www.rqmplus.com/about/team/jaishankar-kutty-phd/)
- [Brandy Chittester, MS](https://www.rqmplus.com/about/team/brandy-chittester-ms/)
- [Torrie DeGennaro](https://www.rqmplus.com/about/team/torrie-degennaro/)
- [Jon Gimbel, PhD](https://www.rqmplus.com/about/team/jon-gimbel-phd/)
- [Noel Keegan](https://www.rqmplus.com/about/team/noel-keegan/)
- [Dr. John Potthoff](https://www.rqmplus.com/about/team/dr-john-potthoff/)
- [David Sockolof](https://www.rqmplus.com/about/team/david-sockolof/)
- [Melissa Orenstein](https://www.rqmplus.com/about/team/melissa-orenstein/)
- [Ronnie Mahofski](https://www.rqmplus.com/about/team/ronnie-mahofski/)
- [Craig Lunsford](https://www.rqmplus.com/about/team/craig-lunsford/)
- [Frank Maier](https://www.rqmplus.com/about/team/frank-maier/)
- [Sandra Bausback-Aballo](https://www.rqmplus.com/about/team/sandra-bausback-aballo/)